Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;332:1333-1334 (3 June), doi:10.1136/bmj.332.7553.1333-b
| The first 150 words of the full text of this article appear below. |
EDITOROwen et al highlight the possibility that intravenous antibiotics may be overprescribed to patients with non-severe community acquired pneumonia.1 The guidelines of the "Surviving Sepsis" campaign for managing severe sepsis and septic shock recommend "intravenous antibiotic treatment should be started within the first hour of recognition of severe sepsis, after appropriate cultures."2
Some of the literature referenced by the Surviving Sepsis campaign uses the fulfilment of two out of four of the criteria for the systemic inflammatory response syndrome and a systolic blood pressure less than 90 mm Hg as indicative of sepsis. Given the difference between these criteria and CURB criteria, a patient apparently not deemed suitable for intravenous antibiotic treatment of pneumonia by the CURB criteria could be recommended for aggressive treatment of sepsis (including central venous and arterial access) by the campaign's guidelines.
This apparent contradiction illustrates the continued importance of overall clinical assessment in
Thomas M Oates, senior house officer
Charing Cross Hospital, London W6 8RF oates_tom@hotmail.com